These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 21198715

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The prophylactic role for the human papillomavirus quadrivalent vaccine in males.
    Yancey AM, Pitlick JM, Forinash AB.
    Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891
    [Abstract] [Full Text] [Related]

  • 5. A human papillomavirus vaccine.
    Med Lett Drugs Ther; 2010; 48(1241-1242):65-6. PubMed ID: 16977280
    [Abstract] [Full Text] [Related]

  • 6. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine.
    Villa LL.
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S17-25. PubMed ID: 18162241
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The human papillomavirus vaccines.
    Ljubojević S.
    Acta Dermatovenerol Croat; 2006 Nov; 14(3):208. PubMed ID: 17010274
    [Abstract] [Full Text] [Related]

  • 9. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 May 28; 59(20):630-2. PubMed ID: 20508594
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA.
    Pharmacotherapy; 2011 Mar 28; 31(3):280-97. PubMed ID: 21361739
    [Abstract] [Full Text] [Related]

  • 13. Protecting our patients from HPV and HPV-related diseases: the role of vaccines.
    Mahoney MC.
    J Fam Pract; 2006 Nov 28; Suppl():10-7. PubMed ID: 17366753
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM, Reynolds SM, Jacobson RM.
    Postgrad Med; 2010 Mar 28; 122(2):121-9. PubMed ID: 20203463
    [Abstract] [Full Text] [Related]

  • 17. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.
    McCormack PL, Joura EA.
    Drugs; 2010 Dec 24; 70(18):2449-74. PubMed ID: 21142263
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
    Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA, Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators.
    N Engl J Med; 2007 May 10; 356(19):1928-43. PubMed ID: 17494926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.